Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
08/31/1995 | WO1995022974A2 Film coated tablet of paracetamol and domperidone |
08/31/1995 | WO1995022966A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
08/31/1995 | CA2184093A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
08/31/1995 | CA2183769A1 Vacuolating toxin-deficient h. pylori and related methods |
08/30/1995 | EP0669134A1 Remedy for wound |
08/30/1995 | EP0668879A1 Truncated insulin-like growth factor binding proteins having mitogenic activity |
08/30/1995 | EP0668872A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
08/30/1995 | EP0668770A1 $g(a)-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY |
08/30/1995 | CN1107473A 4-Arylamino-benzopyran and related compounds |
08/30/1995 | CN1107467A 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
08/29/1995 | US5446230 Platinium, and tin or germenium catalyst deposited on chlorinated alumina used as isomerization catalyst |
08/29/1995 | US5446189 Diester intermediates for diacid enzyme inhibitor |
08/29/1995 | US5446152 Antiemetic agent |
08/29/1995 | US5446052 Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them |
08/29/1995 | US5446049 Azanoradamantanes for treatment of conditions responsive to 5-HT agonists and/or antagonists |
08/29/1995 | US5446046 1,3-dipropyl-8-(3-oxatricyclo(3,1,2,0(2,4-))oct6(7)-Yl)-xanthine used to treat cadiac arrhythmias |
08/29/1995 | CA1336833C Piperidine derivatives |
08/24/1995 | WO1995022348A1 Medical application of bromelain |
08/24/1995 | CA2183866A1 Medical application of bromelain |
08/23/1995 | EP0668075A2 Non-peptide tachykinin receptor antagonists |
08/23/1995 | EP0667870A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b) |
08/23/1995 | EP0667854A1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences |
08/23/1995 | EP0667784A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
08/23/1995 | EP0667770A1 Inhibition of tnf production. |
08/23/1995 | EP0297109B1 Process for the preparation of a viscosity-stable antacid composition |
08/23/1995 | CN1107158A Polysubstituted 2-amino-thiazole derivatives |
08/23/1995 | CN1107146A A process for preparing a composition containing benzoheterocycles |
08/22/1995 | US5444050 Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa |
08/22/1995 | US5443833 Pharmaceutical compositions |
08/22/1995 | CA2030077C Azabicyclo amides and esters as 5-ht _receptor antagonists |
08/22/1995 | CA1336773C Therapeutic dibenzo-piperazino-azepine derivatives |
08/17/1995 | WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
08/17/1995 | WO1995021857A1 Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
08/17/1995 | WO1995021856A1 Carbamoylmethylurea derivative |
08/17/1995 | WO1995021854A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
08/17/1995 | WO1995021843A1 Azacyclic derivatives |
08/17/1995 | WO1995021842A1 Heterocyclic compounds and their preparation and use |
08/17/1995 | WO1995021840A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
08/17/1995 | WO1995021839A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
08/17/1995 | WO1995021819A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists |
08/17/1995 | WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
08/17/1995 | WO1995021611A2 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
08/17/1995 | WO1995021610A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors |
08/17/1995 | CA2183069A1 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
08/17/1995 | CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
08/17/1995 | CA2182957A1 Heterocyclic compounds and their preparation and use |
08/17/1995 | CA2182734A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists |
08/17/1995 | CA2181986A1 Carbamoylmethylurea derivatives |
08/16/1995 | EP0667344A1 3-acylamino-5-(polysubstituted phenyl)-1,4-benzodiazepin-2-ones useful as CCK-receptor agonists |
08/16/1995 | EP0666914A1 Novel p-selectin ligand protein |
08/16/1995 | EP0666856A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
08/16/1995 | EP0666851A1 Substituted phthalazinones as nerotensin antagonists |
08/16/1995 | EP0666849A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
08/16/1995 | EP0666759A1 Preparation for therapeutic and especially prophylactic treatment of digestive tract disorders |
08/16/1995 | EP0666758A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
08/16/1995 | CN1106812A Tricyclic diazepine vasopressin antagonists |
08/16/1995 | CN1106804A 1-Benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives |
08/16/1995 | CN1106802A Tricyclic benzazepine vasopressin antagonists |
08/16/1995 | CN1106690A Medicine of curing hepatitis |
08/16/1995 | CN1106670A External use drug for treatment of odontopathy |
08/16/1995 | CN1106662A Composition for rectal administration |
08/15/1995 | US5442110 Connective tissue disorders |
08/15/1995 | US5442077 Benzo[B]Furancarboxamide derivatives, process for the preparation of same and use thereof for improving hypermotility |
08/15/1995 | US5441748 Agents for distributing gallstones |
08/15/1995 | CA2142411A1 Polysubstituted 3-acylamino-5-phenyl-1,4- benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them |
08/15/1995 | CA2142394A1 Organic compounds |
08/15/1995 | CA1336683C Diagnosis and treatment of double-stranded rna deficiency states |
08/10/1995 | WO1995021245A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof |
08/10/1995 | WO1995020971A1 Therapeutic composition for replacing and/or supplementing body fluids |
08/10/1995 | CA2159217A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof |
08/09/1995 | EP0666263A1 Novel condensed thiazole derivative, process for producing the same, and pharmaceutical composition containing the same |
08/09/1995 | EP0665844A1 Substituted benzylaminoquinuclidines as substance p antagonists |
08/09/1995 | EP0665843A1 Substituted quinuclidines as substance p antagonists |
08/09/1995 | EP0665840A1 Dopamine receptor subtype ligands |
08/09/1995 | EP0665833A1 Dopamine receptor subtype ligands |
08/09/1995 | EP0665754A1 Antimicrobial peptides |
08/09/1995 | EP0665752A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
08/09/1995 | EP0665746A1 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGF$g(a)PE 40?ab |
08/09/1995 | EP0665739A1 Morphogen-induced periodontal tissue regeneration |
08/09/1995 | EP0601123B1 Low speed model following velocity command system for rotary wing aircraft |
08/09/1995 | CN1106288A Oral mushroom liquor |
08/08/1995 | US5439927 For potassium channel opening, hypotensive agents, broncho- or vasodilators, gastrointestinal disorders |
08/08/1995 | US5439917 Active compounds |
08/08/1995 | US5439680 Cell-associated glucosyltransferase, an antibody thereto, and a dental caries prophylactic composition containing said antibody as an effective component |
08/08/1995 | CA1336581C Aloe composition and uses thereof |
08/03/1995 | WO1995020578A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS |
08/03/1995 | WO1995020575A1 Aralkylamino substituted azacyclic therapeutic agents |
08/03/1995 | WO1995020564A1 Leukotriene b4 derivatives, methods of preparing them and their use as drugs |
08/03/1995 | WO1995020402A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments |
08/03/1995 | WO1995020386A1 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
08/03/1995 | WO1995004720A3 Gastrin and cck receptor ligands |
08/03/1995 | CA2182489A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments |
08/03/1995 | CA2181376A1 Aralkylamino substituted azacyclic therapeutic agents |
08/02/1995 | EP0664808A1 Imidazopyridine derivatives as 5-ht 4? receptor antagonists |
08/02/1995 | EP0664806A1 Heterocyclic condensed benzoic acid derivatives as 5-ht 4? receptor antagonists |
08/02/1995 | EP0664805A1 Heterocyclic -esters or -amides used as 5-ht 4? receptor antagonists |
08/02/1995 | EP0664794A1 N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists |
08/02/1995 | EP0664695A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection |
08/02/1995 | EP0489860B1 Methods and compositions for healing ulcers |
08/02/1995 | CN1106007A Novel sulfonylamino pyrimidines |